Phase II trials of idarubicin, a new anthracycline.
Rosso
R
R
Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Ardizzoni
A
A
Conte
P
P
Fusco
V
V
Gulisano
M
M
Lionetto
R
R
Pronzato
P
P
Repetto
L
L
D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use / Q000633:toxicity*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D015255:Idarubicin